Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments

Dina Poplausky, Jade N. Young, Hansen Tai, Ryan Rivera-Oyola, Nicholas Gulati, Rebecca M. Brown

Research output: Contribution to journalReview articlepeer-review


Neurofibromatosis type 1 (NF1) is an autosomal dominant tumor predisposition syndrome that increases one’s risk for both benign and malignant tumors. NF1 affects every organ in the body, but the most distinctive symptoms that are often the most bothersome to patients are the cutaneous manifestations, which can be unsightly, cause pain or pruritus, and have limited therapeutic options. In an effort to increase awareness of lesser-known dermatologic associations and to promote multidisciplinary care, we conducted a narrative review to shed light on dermatologic associations of NF1 as well as emerging treatment options. Topics covered include cutaneous neurofibromas, plexiform neurofibromas, diffuse neurofibromas, distinct nodular lesions, malignant peripheral nerve sheath tumors, glomus tumors, juvenile xanthogranulomas, skin cancer, and cutaneous T-cell lymphoma.

Original languageEnglish
Article number2770
Issue number10
StatePublished - May 2023


  • NF1
  • cutaneous
  • cutaneous neurofibroma
  • glomus tumor
  • neurofibroma
  • neurofibromatosis type 1
  • plexiform neurofibroma


Dive into the research topics of 'Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments'. Together they form a unique fingerprint.

Cite this